Trials / Unknown
UnknownNCT02880787
Comparison of Two Neuromuscular Transmission Monitors Based on Acceleromyography: TOF-Watch SX® and TOFScan®
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 142 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
The purpose is to evaluate the reproducibility of neuromuscular monitoring data of recovery from neuromuscular blockade, obtained with TOFScan® and TOF-Watch SX®, in adult and pediatric population. Secondary purposes are to evaluate the reproducibility of data obtained with 2 monitors for: * the onset of clinical action of curare: suppression of the first response of train of four monitoring (T1) of 95% initial value * the duration of clinical action of curare: recovery of the first response of train of four monitoring (T1) to 25% initial value * recovery of first (T1), second (T2), third (T3) and fourth response (T4) of train of four monitoring, and recovery of T4/T1 to 40% and 60% initial value (T4/T1 0.4 and 0.6) * complete recovery from curarisation, at T4/T1=90% and T4/T1=100%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rocuronium | Anesthesia induction with Propofol and maintaining with desflurane. For adult patients, the curare is rocuronium (0.6 mg/kg) For pediatric patients, the curare can be rocuronium (0.6 mg/kg), cisatracurium (0.1 mg/kg) or atracurium (0.5 mg/kg) |
| DEVICE | Neuromuscular monitoring with TOFScan® and TOF-Watch SX® | Each monitor on one arm |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2016-08-26
- Last updated
- 2016-08-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02880787. Inclusion in this directory is not an endorsement.